Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation
NCT ID: NCT02256358
Last Updated: 2014-10-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2013-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
NCT06624592
Ketamine Versus Propofol as ICU Sedation
NCT06243822
Comparison of Emergence/Dysphoric Reaction Frequency of Using 2 Different Doses Ketamine
NCT05786365
Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity
NCT00440102
Emergence Agitation of Sevoflurane in Pediatric
NCT06830564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midazolam
Intravenous 0.1 mg/kg midazolam was administered to the patients as premedication drug before entering operating room.
Midazolam
preoperatively injected intravenous 0.1 mg/kg midazolam
Ketamine
Intravenous 1 mg/kg ketamine was administered to the patients as premedication drug before entering operating room.
Ketamine
Preoperatively injected intravenous 1mg/kg ketamine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midazolam
preoperatively injected intravenous 0.1 mg/kg midazolam
Ketamine
Preoperatively injected intravenous 1mg/kg ketamine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Years
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inje University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ki Hwa Lee
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kihwa Lee, MD
Role: STUDY_CHAIR
Haeundae paik hospital, inje university
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-127
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.